FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称VISUGROMAB
异名/同义词CTL002
CTL-002
IMMUNOGLOBULIN G4 (226-PROLINE,DE-445-LYSINE), ANTI-(HUMAN GROWTH DIFFERENTIATION FACTOR 15) (HUMAN-MUS MUSCULUS MONOCLONAL CTL-002 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CTL-002 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS GDF15 (GROWTH DIFFERENTIATION FACTOR 15, PLAB, MIC-1, PDF, MIC1, NAG-1, PTGFB)), MONOCLONAL ANTIBODY
VISUGROMAB
VISUGROMAB [INN]
VISUGROMAB [WHO-DD]
CAS登记号2556646-63-8
物质唯一标识(Unique Ingredient Identifier)NX3NW9MM9W
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System